Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo-Shen Lin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|February 23, 2026
Pleiotropic immunoregulation by bile acids in pathophysiologyBo-Shen Lin, Min-Yue Yin, Si-An Xie, et al.
Digestion|April 4, 2023
Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-AnalysisWen-Lin Zhang, Bo-Shen Lin, Yue-Yue Li, et al.
Analytica Chimica Acta|May 26, 2026
Enhanced label-free SERS detection of uremic toxins in clinical spent dialysateHan Lee, Jiunn-Der Liao, Yi-Shan Guo, et al.
The Analyst|April 22, 2024
Advances in uremic toxin detection and monitoring in the management of chronic kidney disease progression to end-stage renal diseaseHan Lee, Kuan-Hung Liu, Yu-Hsuan Yang, et al.
Clinical and Translational Gastroenterology|August 16, 2021
Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot StudyJing Liu, Chao-Ran Ji, Yue-Yue Li, et al.
Journal of Digestive Diseases|July 13, 2022
Implementation of WeChat-based patient-doctor interaction in the management of Helicobacter pylori infection: A propensity score matching analysisBo Shen Lin, Yue Yue Li, Chen Qiao, et al.
Journal of Gastroenterology and Hepatology|September 13, 2023
Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot studyShu-Yan Zeng, Juan Wang, Jing Liu, et al.
Journal of Digestive Diseases|March 24, 2023
Vonoprazan is noninferior to proton pump inhibitors in bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: A propensity score matching analysisJuan Wang, Yue Yue Li, Min Juan Lin, et al.
Journal of Digestive Diseases|July 26, 2022
Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals: A stratified sampling cross-sectional surveyWen Lin Zhang, Yue Yue Li, Jing Liu, et al.
Clinical and Experimental Medicine|December 20, 2022
The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysisYu-Ming Ding, Yue-Yue Li, Jing Liu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|February 23, 2026
Pleiotropic immunoregulation by bile acids in pathophysiologyBo-Shen Lin, Min-Yue Yin, Si-An Xie, et al.
Digestion|April 4, 2023
Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-AnalysisWen-Lin Zhang, Bo-Shen Lin, Yue-Yue Li, et al.
Analytica Chimica Acta|May 26, 2026
Enhanced label-free SERS detection of uremic toxins in clinical spent dialysateHan Lee, Jiunn-Der Liao, Yi-Shan Guo, et al.
The Analyst|April 22, 2024
Advances in uremic toxin detection and monitoring in the management of chronic kidney disease progression to end-stage renal diseaseHan Lee, Kuan-Hung Liu, Yu-Hsuan Yang, et al.
Clinical and Translational Gastroenterology|August 16, 2021
Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot StudyJing Liu, Chao-Ran Ji, Yue-Yue Li, et al.
Journal of Digestive Diseases|July 13, 2022
Implementation of WeChat-based patient-doctor interaction in the management of Helicobacter pylori infection: A propensity score matching analysisBo Shen Lin, Yue Yue Li, Chen Qiao, et al.
Journal of Gastroenterology and Hepatology|September 13, 2023
Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot studyShu-Yan Zeng, Juan Wang, Jing Liu, et al.
Journal of Digestive Diseases|March 24, 2023
Vonoprazan is noninferior to proton pump inhibitors in bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: A propensity score matching analysisJuan Wang, Yue Yue Li, Min Juan Lin, et al.
Journal of Digestive Diseases|July 26, 2022
Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals: A stratified sampling cross-sectional surveyWen Lin Zhang, Yue Yue Li, Jing Liu, et al.
Clinical and Experimental Medicine|December 20, 2022
The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysisYu-Ming Ding, Yue-Yue Li, Jing Liu, et al.
Pageof 2